Abstract |
New protein lysine methyltransferase (PKMT) assays are needed to facilitate screening for improved PKMT inhibitors, because PKMTs are mutated or overexpressed in several cancers. In cells, methylated lysine residues are recognized by reading domains such as the chromodomain of HP1β, which bind to target proteins in a lysine-methylation-specific manner. Herein we describe a sensitive, robust, and non-radioactive high-throughput PKMT assay that employs the HP1β chromodomain to detect the methylation of peptide substrates by the human SUV39H1 and SUV39H2 PKMTs. The assay has a very good dynamic range and high signal-to-noise ratio. It can be used to screen for PKMT inhibitors, as illustrated by analyzing the inhibition of SUV39H1 by chaetocin. The IC50 value of this inhibition was found to be 480 nM, which is close to its published value. Our data indicate that natural reading domains can be used as alternates to methyl-specific antibodies in PKMT assays. Reading domains can be produced recombinantly in E. coli at low cost and consistent quality, and they are accessible to protein design.
|
Authors | Srikanth Kudithipudi, Denis Kusevic, Albert Jeltsch |
Journal | ChemMedChem
(ChemMedChem)
Vol. 9
Issue 3
Pg. 554-9
(Mar 2014)
ISSN: 1860-7187 [Electronic] Germany |
PMID | 23671032
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- CBX1 protein, human
- Piperazines
- Chromobox Protein Homolog 5
- chaetocin
- Histone-Lysine N-Methyltransferase
|
Topics |
- Chromobox Protein Homolog 5
- Enzyme Assays
(methods)
- Histone-Lysine N-Methyltransferase
(analysis, antagonists & inhibitors, metabolism)
- Humans
- Inhibitory Concentration 50
- Piperazines
(chemistry, pharmacology)
- Structure-Activity Relationship
|